BE509487A - - Google Patents
Info
- Publication number
- BE509487A BE509487A BE509487DA BE509487A BE 509487 A BE509487 A BE 509487A BE 509487D A BE509487D A BE 509487DA BE 509487 A BE509487 A BE 509487A
- Authority
- BE
- Belgium
- Prior art keywords
- phenyl
- beta
- diethylaminoethyl
- hydroxybenzoate
- mandelate
- Prior art date
Links
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 claims description 9
- HLDCSYXMVXILQC-UHFFFAOYSA-N xenysalate Chemical compound CCN(CC)CCOC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1O HLDCSYXMVXILQC-UHFFFAOYSA-N 0.000 description 10
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 7
- 229960002510 mandelic acid Drugs 0.000 description 7
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 230000000855 fungicidal effect Effects 0.000 description 3
- -1 mandelate ester salt Chemical class 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000083 urinary anti-infective agent Substances 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IBBPBOICXYUQID-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-hydroxy-3-phenylbenzoate;hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1O IBBPBOICXYUQID-UHFFFAOYSA-N 0.000 description 1
- ZJWUEJOPKFYFQD-UHFFFAOYSA-N 2-hydroxy-3-phenylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1O ZJWUEJOPKFYFQD-UHFFFAOYSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE509487A true BE509487A (enrdf_load_html_response) |
Family
ID=148899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE509487D BE509487A (enrdf_load_html_response) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE509487A (enrdf_load_html_response) |
-
0
- BE BE509487D patent/BE509487A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0495802A1 (fr) | Compose de phosphonium, composition le contenant et procede de desinfection | |
EP0411111B1 (fr) | Compose d'ammonium, composition le contenant et procede de desinfection | |
BE509487A (enrdf_load_html_response) | ||
JPH02193948A (ja) | 抗微生物性を有する化合物及びその製造法 | |
EP0136195B1 (fr) | Dérivés de la benzamidine à activité antimicrobienne, procédé d'obtention et application à titre de médicaments désinfectants ou conservateurs | |
EP0135433B1 (fr) | Dérivés de l'acide benzoique pour utilisation comme médicament et utilisation de ces dérivés comme agents conservateurs ou désinfectants | |
CH616400A5 (en) | Process for production of hydroxylated amines having bacteriostatic activity | |
EP0198366A1 (en) | Novel 5-alkylsulfonylsalicylanlides and microbiocidal compositions for controlling the growth of microorganisms | |
EP0037780B1 (fr) | Alcoxy propanolamines utiles comme médicaments et procédé pour leur préparation | |
FR2492821A1 (fr) | Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant | |
CH410906A (fr) | Procédé de préparation de la 3-phénoxy-propylguanidine | |
JP3082891B2 (ja) | 工業用水の殺菌方法 | |
EP0146450B1 (fr) | Dérivés de beta-[2-(Halogénobenzyl-)-phénoxy] -éthylamine, procédé de préparation et utilisation en thérapeutique. | |
EP0037781B1 (fr) | Phényl alcoxy propanolamines, leur préparation et leur application en tant que médicaments | |
FR2471973A1 (fr) | Procede de preparation de cyanoacetates d'alkyle | |
CN106966939B (zh) | 一种四烷基过氧化羧酸铵盐化合物及其制备方法与应用 | |
FR2507180A1 (fr) | Nouvelles phenylalkylamines, leur preparation et leur application comme medicaments | |
FR2528840A1 (fr) | N-(3-(4-(3-fluorobenzyloxy) phenoxy)propyl) morpholine, son procede de preparation et son application en therapeutique | |
JPS6229564A (ja) | 3―(3―アイオドプロパルギルオキシ)―プロピオニトリル,その製法およびそれを含有する工業用殺微生物剤 | |
FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
BE458103A (enrdf_load_html_response) | ||
BE903568A (fr) | Nouveaux composes chimiques a activites antiphlogistiques, antiseptiques et detergentes | |
BE561112A (enrdf_load_html_response) | ||
BE456506A (enrdf_load_html_response) | ||
CH294504A (fr) | Procédé de préparation d'un sel d'une halo-amine tertiaire. |